Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-30 11:23 am Purchase |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FARALLON CAPITAL PARTNERS LP | 2,205,990 9.990% |
788,073![]() (+55.58%) |
Filing History |
2024-01-29 5:01 pm Sale |
2024-01-25 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
0 0.000% |
-3,978,540![]() (Position Closed) |
Filing History |
2024-01-26 4:19 pm Sale |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Integrated Core Strategies (US) LLC | 6,610 0.000% |
-981,102![]() (-99.33%) |
Filing History |
2024-01-12 5:00 pm Purchase |
2024-01-02 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
RA Capital Management, L.P. | 3,073,119 8.700% |
3,073,119![]() (New Position) |
Filing History |
2024-01-10 4:12 pm Unchanged |
2024-01-08 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 11.260% |
0 (Unchanged) |
Filing History |
2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,947,316 9.472% |
-953,076![]() (-32.86%) |
Filing History |
2023-04-19 9:48 pm Purchase |
2023-04-12 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Prosight Management LP | 948,012 4.900% |
948,012![]() (New Position) |
Filing History |
2023-03-27 4:27 pm Unchanged |
2023-02-07 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 17.300% |
0 (Unchanged) |
Filing History |
2023-03-10 09:30 am Purchase |
2023-03-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 2,900,392 14.999% |
1,795,488![]() (+162.50%) |
Filing History |
2023-02-14 4:01 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
HBM BIOVENTURES CAYMAN LTD | 1,345,009 9.990% |
17,579![]() (+1.32%) |
Filing History |
2023-02-14 3:05 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,801,947 9.990% |
420,015![]() (+30.39%) |
Filing History |
2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 1,510,961 11.100% |
-513,655![]() (-25.37%) |
Filing History |
2023-02-13 8:33 pm Purchase |
2023-02-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Point72 Asset Management, L.P. | 1,250,000 6.500% |
1,250,000![]() (New Position) |
Filing History |
2023-02-09 12:48 pm Sale |
2023-02-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FMR CORP | 1,104,904 8.132% |
-410,678![]() (-27.10%) |
Filing History |
2023-02-03 5:15 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FARALLON CAPITAL PARTNERS LP | 1,417,917 9.990% |
1,417,917![]() (New Position) |
Filing History |
2023-01-25 4:38 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Integrated Core Strategies (US) LLC | 987,712 7.300% |
212,232![]() (+27.37%) |
Filing History |
2022-03-21 4:25 pm Purchase |
2022-03-11 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 23.100% |
3,978,540![]() (New Position) |
Filing History |
2022-03-10 4:43 pm Purchase |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
ARENA PHARMACEUTICALS INC ARNA |
3,978,540 23.100% |
3,978,540![]() (New Position) |
Filing History |
2022-02-14 3:16 pm Purchase |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,381,932 9.990% |
42,301![]() (+3.16%) |
Filing History |
2022-02-14 2:35 pm Sale |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
PRICE T ROWE ASSOCIATES INC | 2,024,616 14.900% |
-278,133![]() (-12.08%) |
Filing History |